Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist
Crossref DOI link: https://doi.org/10.1007/164_2021_443
Published Online: 2021-04-09
Published Print: 2021
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Yan
Freeman, Kevin
Setola, Vincent
Cao, Danni
Kaski, Shane
Kreek, Mary Jeanne
Liu-Chen, Lee-Yuan
Text and Data Mining valid from 2021-01-01
Version of Record valid from 2021-01-01
Chapter History
First Online: 9 April 2021